What's breaking now, across thousands of outlets.
Russia has shared little information about how a researcher in Siberia died from a "pneumonia of unknown origin.”
We haven't written up this one. Forbes has the full story — the link below goes straight to it.
Mumbai: Three months after the Maharashtra Food and Drug Administration (FDA) busted an alleged Rs 11.48-crore synthetic milk racket spread across multiple districts, the investigation has uncovered…
Centers for Disease Control and Prevention director Erica Schwartz said on Wednesday the risk to the U.S. from an unconfirmed pneumonic plague case in Siberia is extremely low, but the agency is…
GENEVA — The death of a pathogen researcher in Siberia has raised concerns about the pneumonic plague, as Russian authorities provide little information publicly.
A Dutch court has ordered Merck to stop manufacturing and selling its injectable formulation of Keytruda in eight European countries. The court ruled that Merck infringed one of Halozyme's patents and
Ultragenyx Pharmaceutical is selling a priority review voucher to an undisclosed buyer for $210 million, marking one of the richest sales of the speedy-approval tool so far this year.
Collins said that veterans should specifically look beyond wait times and focus more on the quality of care they receive.
